Neurology and the blood: Haematological abnormalities in ischaemic stroke

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue 2, 1998, Pages 150-159

  Markus, Hugh S ^a,c   Hambley, Henry ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Haematological abnormalities; Ischaemic stroke

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; ANTITHROMBIN III CONCENTRATE; CARDIOLIPIN ANTIBODY; FIBRIN; HEPARIN COFACTOR II; LUPUS ANTICOAGULANT; NITRIC OXIDE; PHOSPHOLIPID ANTIBODY; PLASMINOGEN; PROTEIN C; PROTEIN S; THROMBIN; THROMBOMODULIN;

ACTIVATED PROTEIN C RESISTANCE; ANTITHROMBIN III DEFICIENCY; ARTICLE; BLOOD FLOW; BLOOD VISCOSITY; CONGENITAL BLOOD CLOTTING DISORDER; DISSEMINATED INTRAVASCULAR CLOTTING; EXCHANGE BLOOD TRANSFUSION; HEMATOLOGIC DISEASE; HUMAN; LEUKEMIA; LUPUS ERYTHEMATOSUS; LYMPHOMA; NEOPLASM; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PARAPROTEINEMIA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PLASMAPHERESIS; POLYCYTHEMIA VERA; PREGNANCY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PUERPERIUM; SICKLE CELL ANEMIA; STROKE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0031947743     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.64.2.150     Document Type: Article

References (85)

1. Marcus AJ, Webster BB, Jaffe EA, et al. Synthesis of prostacyclin from platelet derived endoperoxides by cultured human endothelial cells. J Clin Invest 1980;60:979-86.
2. Radomski MW, Moncada S. Regulation of vascular haemostasis by nitric oxide. Thromb Haeomost 1993;70:36-41.
3. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964;145:1310-2.
4. MacFarlane RG. An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier. Nature 1964;202:498-9.
5. Hart RG, Kanter MC. Haematological disorders and ischaemic stroke: a selective review. Stroke 1990;21:1111-21.
6. Rosove MH, Hocking WG, Canobbio MM, et al. Cronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet 1986;ii:313-5.
7. Lubarsky Da, Gallagher CJ, Berend JL. Secondary poly-cythaemia does not increase the risk of perioperative haemorrhagic or thrombotic complications. J Clin Anest 1991;3: 99-103.
8. Preston FE, Martin JF, Stewart RM, et al. Thrombocytosis, circulating platelet aggregates and neurological dysfunction. BMJ 1979;ii:1561-3.
9. Jabaily J, Iland HJ, Laszlo J, et al. Neurologic manifestations of essential thrombocythaemia. Ann Intern Med 1983;99: 513-8.
10. Schafer AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984;64:1-12.
11. Wood DH. Cerebrovascular complications of sickle cell anaemia. Stroke 1978;9:73-5.
12. Adams RJ, Nichols FT, McVie V, et al. Cerebral infarction in sickle cell anaemia: mechanism based on CT and MRI. Neurology 1988;38:1012-7.
13. Glauser TA, Siegel MJ, DeBaun MR. Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell haemoglobinopathy. J Child Neurol 1995;10:88-92.
14. Adams R, Mckie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992;326:605-10.
15. Fabian RH, Peters BH. Neurological complications of haemoglobin SC disease. Arch Neurol 1984;41:289-92.
16. Handin RI. Disorders of the platelet and vessel wall. In: Issenbacher KJ, Braundwell E, Wilson JD, et al, eds. Harrison's principles of internal medicine. 13th ed. New York: McGrawHill, 1994:1798-803.
17. Coull BM, Clark WM. Abnormalities of haemostasis in ischaemic stroke. Med Clin 1993;77:77-94.
18. Silverstein A. Thrombotic thrombocytopenic purpure; the initial neurological manifestations. Arch Neurol 1968;18: 358-62.
19. Ridolfi RL, Bell WR. Thrombotic thrombocytopenic purpure; report of 25 cases and review of the literature. Medicine 1981;60:413-28.
20. Kay AC, Solberg LA, Nichols DA, et al. Prognostic significance of computed tomography of the brain in thrombotic thrombocytopenic purpure. Mayo Clin Proc 1991;66:602-7.
21. Sheth KJH, Swick HM, Haworth N. Neurological involvement in haemorytic-uraemic syndrome. Ann Neurol 1986; 19:90-93.
22. Handin RI. Disorders of coagulation and thrombosis. In: Issenbacher KJ, Braundwell E, Wilson JD, et al. Harrison's principles of internal medicine. 13th ed. New York: McGraw Hill, 1994:1804-13.
23. Becker PS, Miller VT. Heparin-induced thrombocytopenia. Stroke 1989;20:1449-59.
24. Massey EW, Riggs JE. Neurologic manifestations of haematologic disease. Neurol Clin 1989;7:549-60.
25. Demirer T, Dail DH, Aboulafia DM. Four varied cases of intravascular lymphomatosis and a literature review. Cancer 1984;76:1738-15.
26. Williams DB, Lyons MK, Takehiko Y, et al. Cerebral angiotrophic large cell lymphoma (neoplastic angioendotheliosis) therapeutic considerations. J Neurol Sci 1991;103:16-21.
27. Glass J. Hochberg FH, Miler DC. Intravascular lymphomatosis. A systemic disease with neurologic manifestatoins. Cancer 1993;71:3156-64.
28. Lennox IM, Zeeh J, Currie N, et al. Malignant angioendotheliosis - an unusual cause of stroke. Scot Med J 1989;34:407-8.
29. Lie JT. Malignant angioendotheliomatosis (intravascular lymphomatosis) clinically simulating primary angiitis of the central nervous system. Arthritis Rheum 1992:57:831-4.
30. Roux S, Grossin M, De Bandt M, et al. Angiotropic large cell lymphoma with mononeuritis multiplex mimicking systemic vasculitis. J Neurol Neurosurg Psychiatry 1995;58: 363-6.
31. Tuddenham EGD. Thrombophilia: a new factor emerges from the mists. Lancet 1993;342:1501-2.
32. Miletich J, Sherman L, Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. Semin Thromb Hemost 1990;16:166-76.
33. Tait RC, Walker ID, Islam SIAM, et al. Protein C activity in healthy volunteers - influence of age, sex, smoking, and oral contraceptives. Thomb Haemost 1993;70:281-5.
34. Gladson CL, Scharrer I, Hach V, et al. The frequency of type 1 heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 1988;59:18-22.
35. Israels SJ, Seshia SS. Childhood stroke associated with protein C or protein S deficiency. J Pediatr 1987;111:562-4.
36. Grewall RP, Goldbert MA. Stroke in protein C deficiency. Am J Med 1990;89:538-9.
37. Kohler J, Kasper J, Witt I, et al. Ischaemic stroke due to protein C deficiency. Stroke 1990;21:1077-80.
38. Camerlingo M, Finazzi G, Caato L, et al. Inherited protein C deficiency and non-haemorrhagic arterial stroke in young adults. Neurology 1991;41:1371-3.
39. Simioni P, De Rone H, Prandoni P, et al. Ischaemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke 1995;26:885-90.
40. Martinez RA, Rangel-Guerra HR, Marfil LJ. Ischaemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults. Stroke 1993;24:19-25.
41. Van Kuijck MAP, Rotteveel JJ, Van Oostrom CG, et al. Neurological complications in children with protein C deficiency. Neuropaediatrics 1994;25:16-9.
42. D'Angelo A, Landi G, Vigano d'Angelo S, et al. Protein C in acute stroke. Stroke 1988;19:579-83.
43. Kennedy CR, Warner G, Kai M, et al. Protein C deficiency and stroke in early life. Dev Med Child Neurol 1995;37:723-30.
44. Tadisumak T, Fisher M. Hematologic disorders associated with ischaemic stroke. J Neurol Sci 1996;140:1-11.
45. Broekmans AW, Van der Linden IK, Jansen Y, et al. Prevalence of protein C (PC) and protein S (PS) deficiency in patients with thrombotic disease. Thromb Res 1986; (suppl VI) 268.
46. Barinagarrementeria F, Cant A, Cant-Brio C, et al. Prothrombotic states in young people with idiopathic stroke. A prospective study. Stroke 1994;25:287-90.
47. Green D, Otoya J, Oriba H, et al. Protein S deficiency in middle-aged women with stroke. Neurology 1992;42:1029-33.
48. Sacco RL, Owen J, Mohr JP, et al. Free protein S deficiency: a possible association with cerebrovascular occlusion. Stroke 1989;20:75-80.
49. Davous P, Horelloyu M, Conard J, et al. Cerebral infarction and familial protein S deficiency. Stroke 1990;21:1760-1.
50. Mayer SA, Sacco RL, Hurlet A, et al. Free protein S deficiency in acute ischaemic stroke. Stroke 1993;24:224-7.
51. Svensson PJ, Dahlback B. Resistance to activated protein C as a basis to venous thrombosis. N Engl J Med 1994;330:517-22.
52. Bertina RM, Koelman BPC, Rosendall FR, et al. Mutation in the blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
53. Halbmayer WM, Haushofer A, Schon R, et al. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and healthy subjects. Blood Coagul Fibinolysis 1994;5:54-9.
54. Ridker PM, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912-7.
55. Catto A, Carter A, Ireland H, et al. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vasc Biol 1995; 15:783-5.
56. Press RD, Liu X-Y, Bearner N, et al. Ischaemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C. Stroke 1996;27:44-8.
57. Markus HS, Zhang Y, Jeffery S. Screening for the factor-V Arg 506 Gln mutation in patients with TIA and stroke. Cerebrovasc Dis 1996;6:360-2.
58. Van der Bom JG, Bots ML, Havekate F, et al. Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. Ann Intern Med 1996;125: 265-9.
59. Lane DA, Caso R. Antithrombin: structure, genomic organisation, function and inherited deficiency. Clin Haematol 1989;2:961-98.
60. Rosenberg RD. Actions and interactions of antithrombin and heparin. N Engl JMed 1975;202:146-51.
61. Bock SC, Harris JF, Balazs I, et al. Assignment of the human antithrombin III structural gene to chromosome Iq23-q25. Cytogenet Cell Genet 1985;39:67-70.
62. Menache D. Replacement therapy in patients with hereditary antithrombin III deficiency. Semin Hematol 1991;28: 31-8.
63. Odegaard OP, Abildgaard U. Antithrombin III: critical review of assay methods. Significance of variations in health and disease. Haemostasis 1978;7:127-34.
64. Vomberg PP, Breederveld C, Fluery P, et al. Cerebral thromboembolism due to antithrombin III deficiency in two children. Neuropaediatrics 1987;18:42-4.
65. Simioni P, Zanardi S, Saracino A, et al. Occurrence of arterial thrombosis in a cohort of patients with hereditary deficiency of clotting inhibitors. J Med 1992;23:61-4.
66. Arima T, Motomura M, Nishiura Y, et al. Cerebral infarction in a heterozygous with variant antithrombin III. Stroke 1992;23:1822-5.
67. Graham JA, Daly HM, Carson PJ. Antithrombin III deficiency and cerebrovascular accidents in young adults. J Clin Pathol 1992;45:921-2.
68. Hathaway WE. Clinical aspects of antithrombin III deficiency. Semin Haematol 1991;28:19-23.
69. Menache D. Antithrombin III concentrates. Hematol Oncol Clin North Am 1992;6:1115-20.
70. Furlan AJ, Lucas FV, Craciun R, et al. Stroke in a young adult with familial plasminogen disorder. Stroke 1991;22: 1598-602.
71. Nagayama T, Shinohara Y, Nagayama M, et al. Congenitally abnormal plasminogen in juvenile ischaemic cerebrovascular disease. Stroke 1993;24:2104-7.
72. Hughes GRV. The antiphospholipid syndrome: 10 years on. Lancet 1993;342:341-4.
73. Montalban J, Khamashta M, Davalos A, et al. Value of immunologic testing in stroke patients. A prospective multicentre study. Stroke 1994;25:2412-5.
74. Brey RL, Hart RG, Sherman DG, et al. Antiphospholipid antibodies and cerebral ischaemia in young people. Neurology 1990;40:1190-6.
75. Muir KW, Squire IB, Alwan W, et al. Anticardolipin antibodies in an unselected stroke population. Lancet 1994;344:452-6.
76. The Antiphospholipid Antibodies Stroke Study Group (APASS). Anticardolipin antibodies and the risk of recurrent thrombo-occlusive events and death. Neurology 1997;48:91-4.
77. Koller H, Stoll G, Sitzer M, et al. Deficiency of both protein C and protein S in a family with ischaemic strokes in young adults. Neurology 1994;44:1238-40.
78. Khamashta MA, Cuadrado MJ, Mujie F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-7.
79. Grosset DG, Ebrahim S, Bone I, et al. Stroke in pregnancy and the pueperium; what magnitude of risk? J Neurol Neurosurg Psychiatry 1995;58:129-31.
80. Srinivasan K. Cerebral venous and arterial thrombosis in pregnancy and pueperium; a study of 135 patients. Angiology 1983;35:731-46.
81. Cant C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and pueperium; review of 67 cases. Stroke 1993;24:1880-4.
82. Royal College of General Practitioners Oral Contraceptive Study. Incidence of arterial disease among oral contraceptive users. Journal of the Royal College of General Practitioners 1983;33:75-82.
83. Vessey NP, Lawless N, Yeates D. Oral contraceptives and stroke; findings in a large prospective study. BMJ 1984;298:530-1.
84. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischaemic stroke and combined oral contraceptives; results of an international, multi centre, case-controlled study. Lancet 1996;348:498-505.
85. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk and combined oral contraceptives; results of an international, multi centre, case-controlled study. Lancet 1996;348:505-10.